Three early Christmas presents… but what will be the New Year’s resolutions?

November was an amazing month for the myeloma community: FDA approval for three new therapies. The very good, but challenging problem is how to integrate and use these three new agents within the recommended treatment protocols for myeloma patients.

First monoclonal antibody approved